Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects (NSERC partnered)

University of Toronto

$187,500.00

MRI-Guided Focal Ablation of Prostate Cancerous Tissue

FY 2009-10

Summary
"The prostate is a multi-purpose organ that is composed of a fibro-muscular tissue that aids in continence by providing an active resistance component to the urethra that passes through it. Also, the prostate is active in the production of seminal fluid. Prostate cancer is the second most common type and most common cause of cancer in males, with more than 230,000 diagnosed each year in North America. Conventional therapy of prostate cancer (prostectomy, radiation) assumes the cancer is distributed throughout the prostate and aims to remove or damage the entire prostate. The traditional treatments are reasonably effective for localized cancer but are associated with a significant reduction in the quality of life, including: incontinence, impotence, bowel dysfunction, and prolonged recovery. While most believe that prostate cancer is a multi-focal disease, recent evidence supports the notion of a dominant focus that is by far the largest of intra-prostatic cancer sites and the major source of extra-prostatic spread. Focal therapy assumes that there is only one clinically important area of cancer within the prostate. We believe that image-guided focal ablation of the dominant focus in selected men with low-grade, low-volume cancer will control the spread of prostate cancer in the majority of men and render it a chronic disease that is largely devoid of side effects. An attractive implementation of this concept would be with a minimally invasive, robot-assisted MRI-guided system. MRI provides the potential to maximize efficacy through target identification, as well as image-guided targeting. Prostatic interventions in closed-bore MRI must be performed by remote control since the medical staff has no access to the patient located inside the scanner. An alternative to robot-assisted focal ablation is manually-assisted intervention guided by real-time MR images. We are fusing both approaches in one robot device. This technology presents difficult challenges that will be addressed in the proposed research program. In particular, the insertion of the surgical needle into the prostate generates some unwanted motion of the gland that requires re-alignment of the surgical tool. Another challenge is the deflection of the surgical tool due to the variation in the stiffness of the different layers of tissue. Finally, feedback through the robot hand controller must be provided to reflect the forces occurring at the interaction between the tool and tissue."
Program
Collaborative Health Research Projects (NSERC partnered)
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
198804
Name
Goldenberg Andrew A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Natural Sciences and Engineering Research Council of Canada (NSERC)
Instname2
Unable to allocate
Prcname2
Collaborative Health Research Projects - NSERC Partnered
Projecttitle
MRI-Guided Focal Ablation of Prostate Cancerous Tissue
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$187,500
Cihrequipment2
$0
Programname2
Collaborative Health Research Projects (NSERC partnered)
Keyworddelim
Mri-Guided
Abstract
"The prostate is a multi-purpose organ that is composed of a fibro-muscular tissue that aids in continence by providing an active resistance component to the urethra that passes through it. Also, the prostate is active in the production of seminal fluid. Prostate cancer is the second most common type and most common cause of cancer in males, with more than 230,000 diagnosed each year in North America. Conventional therapy of prostate cancer (prostectomy, radiation) assumes the cancer is distributed throughout the prostate and aims to remove or damage the entire prostate. The traditional treatments are reasonably effective for localized cancer but are associated with a significant reduction in the quality of life, including: incontinence, impotence, bowel dysfunction, and prolonged recovery. While most believe that prostate cancer is a multi-focal disease, recent evidence supports the notion of a dominant focus that is by far the largest of intra-prostatic cancer sites and the major source of extra-prostatic spread. Focal therapy assumes that there is only one clinically important area of cancer within the prostate. We believe that image-guided focal ablation of the dominant focus in selected men with low-grade, low-volume cancer will control the spread of prostate cancer in the majority of men and render it a chronic disease that is largely devoid of side effects. An attractive implementation of this concept would be with a minimally invasive, robot-assisted MRI-guided system. MRI provides the potential to maximize efficacy through target identification, as well as image-guided targeting. Prostatic interventions in closed-bore MRI must be performed by remote control since the medical staff has no access to the patient located inside the scanner. An alternative to robot-assisted focal ablation is manually-assisted intervention guided by real-time MR images. We are fusing both approaches in one robot device. This technology presents difficult challenges that will be addressed in the proposed research program. In particular, the insertion of the surgical needle into the prostate generates some unwanted motion of the gland that requires re-alignment of the surgical tool. Another challenge is the deflection of the surgical tool due to the variation in the stiffness of the different layers of tissue. Finally, feedback through the robot hand controller must be provided to reflect the forces occurring at the interaction between the tool and tissue."
Competitiondate
200910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Goldenberg, Andrew A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $187,500~ $0~